{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T10:08:57Z","timestamp":1790762937704,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,7,22]],"date-time":"2019-07-22T00:00:00Z","timestamp":1563753600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,22]],"date-time":"2019-07-22T00:00:00Z","timestamp":1563753600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s11011-019-00464-7","type":"journal-article","created":{"date-parts":[[2019,7,22]],"date-time":"2019-07-22T09:04:13Z","timestamp":1563786253000},"page":"1565-1575","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Novel mutations in SLC16A2 associated with a less severe phenotype of MCT8 deficiency"],"prefix":"10.1007","volume":"34","author":[{"given":"Silvia","family":"Masnada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Groenweg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Saletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Chiapparini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Castellotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ettore","family":"Salsano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Edward","family":"Visser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9371-7454","authenticated-orcid":false,"given":"Davide","family":"Tonduti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,22]]},"reference":[{"issue":"4","key":"464_CR1","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1177\/088307380201700416","volume":"17","author":"J Arii","year":"2002","unstructured":"Arii J, Tanabe Y, Makino M, Sato H, Kohno Y (2002) Children with irreversible brain damage associated with hypothyroidism and multiple intracranial calcifications. J Child Neurol 17(4):309\u2013313. \nhttps:\/\/doi.org\/10.1177\/088307380201700416","journal-title":"J Child Neurol"},{"issue":"7","key":"464_CR2","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1002\/humu.22331","volume":"34","author":"Y Capri","year":"2013","unstructured":"Capri Y, Friesema EC, Kersseboom S, Touraine R, Monnier A, Eymard-Pierre E, Des Portes V, De Michele G, Brady AF, Boespflug-Tanguy O, Visser TJ, Vaurs-Barriere C (2013) Relevance of different cellular models in determining the effects of mutations on SLC16A2\/MCT8 thyroid hormone transporter function and genotype-phenotype correlation. Hum Mutat 34(7):1018\u20131025. \nhttps:\/\/doi.org\/10.1002\/humu.22331","journal-title":"Hum Mutat"},{"issue":"1","key":"464_CR3","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1590\/S0004-27302011000100008","volume":"55","author":"HC de Menezes-Filho","year":"2011","unstructured":"de Menezes-Filho HC, Marui S, Manna TD, Brust ES, Radonsky V, Kuperman H, Dichtchekenian V, Setian N, Damiani D (2011) Novel mutation in MCT8 gene in a Brazilian boy with thyroid hormone resistance and severe neurologic abnormalities. Arq Bras Endocrinol Metabol 55(1):60\u201366. \nhttps:\/\/doi.org\/10.1590\/S0004-27302011000100008","journal-title":"Arq Bras Endocrinol Metabol"},{"issue":"1","key":"464_CR4","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1086\/380999","volume":"74","author":"AM Dumitrescu","year":"2004","unstructured":"Dumitrescu AM, Liao XH, Best TB, Brockmann K, Refetoff S (2004) A novel syndrome combining thyroid and neurological abnormalities is associated with mutations in a monocarboxylate transporter gene. Am J Hum Genet 74(1):168\u2013175. \nhttps:\/\/doi.org\/10.1086\/380999","journal-title":"Am J Hum Genet"},{"issue":"41","key":"464_CR5","doi-asserted-by":"publisher","first-page":"40128","DOI":"10.1074\/jbc.M300909200","volume":"278","author":"EC Friesema","year":"2003","unstructured":"Friesema EC, Ganguly S, Abdalla A, Manning Fox JE, Halestrap AP, Visser TJ (2003) Identification of monocarboxylate transporter 8 as a specific thyroid hormone transporter. J Biol Chem 278(41):40128\u201340135. \nhttps:\/\/doi.org\/10.1074\/jbc.M300909200","journal-title":"J Biol Chem"},{"issue":"9443","key":"464_CR6","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1016\/S0140-6736(04)17226-7","volume":"364","author":"EC Friesema","year":"2004","unstructured":"Friesema EC, Grueters A, Biebermann H, Krude H, von Moers A, Reeser M, Barrett TG, Mancilla EE, Svensson J, Kester MH, Kuiper GG, Balkassmi S, Uitterlinden AG, Koehrle J, Rodien P, Halestrap AP, Visser TJ (2004) Association between mutations in a thyroid hormone transporter and severe X-linked psychomotor retardation. Lancet 364(9443):1435\u20131437. \nhttps:\/\/doi.org\/10.1016\/S0140-6736(04)17226-7","journal-title":"Lancet"},{"issue":"11","key":"464_CR7","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1210\/me.2005-0256","volume":"20","author":"EC Friesema","year":"2006","unstructured":"Friesema EC, Kuiper GG, Jansen J, Visser TJ, Kester MH (2006) Thyroid hormone transport by the human monocarboxylate transporter 8 and its rate-limiting role in intracellular metabolism. Mol Endocrinol 20(11):2761\u20132772. \nhttps:\/\/doi.org\/10.1210\/me.2005-0256","journal-title":"Mol Endocrinol"},{"issue":"6","key":"464_CR8","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1210\/me.2007-0112","volume":"22","author":"EC Friesema","year":"2008","unstructured":"Friesema EC, Jansen J, Jachtenberg JW, Visser WE, Kester MH, Visser TJ (2008) Effective cellular uptake and efflux of thyroid hormone by human monocarboxylate transporter 10. Mol Endocrinol 22(6):1357\u20131369. \nhttps:\/\/doi.org\/10.1210\/me.2007-0112","journal-title":"Mol Endocrinol"},{"issue":"7","key":"464_CR9","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1210\/er.2008-0019","volume":"29","author":"B Gereben","year":"2008","unstructured":"Gereben B, Zavacki AM, Ribich S, Kim BW, Huang SA, Simonides WS, Zeold A, Bianco AC (2008) Cellular and molecular basis of deiodinase-regulated thyroid hormone signaling. Endocr Rev 29(7):898\u2013938. \nhttps:\/\/doi.org\/10.1210\/er.2008-0019","journal-title":"Endocr Rev"},{"issue":"2","key":"464_CR10","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1210\/en.2013-1521","volume":"155","author":"S Groeneweg","year":"2014","unstructured":"Groeneweg S, Friesema EC, Kersseboom S, Klootwijk W, Visser WE, Peeters RP, Visser TJ (2014) The role of Arg445 and Asp498 in the human thyroid hormone transporter MCT8. Endocrinology 155(2):618\u2013626. \nhttps:\/\/doi.org\/10.1210\/en.2013-1521","journal-title":"Endocrinology"},{"issue":"2","key":"464_CR11","doi-asserted-by":"publisher","first-page":"90","DOI":"10.17925\/USE.2016.12.02.90","volume":"12","author":"S Groeneweg","year":"2016","unstructured":"Groeneweg S, Peeters RP, Visser TJ, Visser WE (2016) Diagnostic and therapeutic challenges in the Allan\u2013Herndon\u2013Dudley syndrome. US Endocrinology 12(2):90\u201393. \nhttps:\/\/doi.org\/10.17925\/USE.2016.12.02.90","journal-title":"US Endocrinology"},{"issue":"10","key":"464_CR12","doi-asserted-by":"publisher","first-page":"3292","DOI":"10.1210\/en.2017-00082","volume":"158","author":"S Groeneweg","year":"2017","unstructured":"Groeneweg S, Lima de Souza EC, Meima ME, Peeters RP, Visser WE, Visser TJ (2017a) Outward-Open Model of Thyroid Hormone Transporter Monocarboxylate Transporter 8 Provides Novel Structural and Functional Insights. Endocrinology 158(10):3292\u20133306. \nhttps:\/\/doi.org\/10.1210\/en.2017-00082","journal-title":"Endocrinology"},{"issue":"2","key":"464_CR13","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.beem.2017.05.001","volume":"31","author":"S Groeneweg","year":"2017","unstructured":"Groeneweg S, Visser WE, Visser TJ (2017b) Disorder of thyroid hormone transport into the tissues. Best Pract Res Clin Endocrinol Metab 31(2):241\u2013253. \nhttps:\/\/doi.org\/10.1016\/j.beem.2017.05.001","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"3","key":"464_CR14","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1210\/en.2017-00846","volume":"159","author":"S Groeneweg","year":"2018","unstructured":"Groeneweg S, van den Berge A, Meima ME, Peeters RP, Visser TJ, Visser WE (2018) Effects of chemical chaperones on thyroid hormone transport by MCT8 mutants in patient-derived fibroblasts. Endocrinology 159(3):1290\u20131302. \nhttps:\/\/doi.org\/10.1210\/en.2017-00846","journal-title":"Endocrinology"},{"issue":"Pt 2","key":"464_CR15","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1093\/brain\/114.2.825","volume":"114","author":"JP Halpern","year":"1991","unstructured":"Halpern JP, Boyages SC, Maberly GF, Collins JK, Eastman CJ, Morris JG (1991) The neurology of endemic cretinism. A study of two endemias. Brain 114(Pt 2):825\u2013841","journal-title":"Brain"},{"issue":"4","key":"464_CR16","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1210\/edrv.22.4.0435","volume":"22","author":"G Hennemann","year":"2001","unstructured":"Hennemann G, Docter R, Friesema EC, de Jong M, Krenning EP, Visser TJ (2001) Plasma membrane transport of thyroid hormones and its role in thyroid hormone metabolism and bioavailability. Endocr Rev 22(4):451\u2013476. \nhttps:\/\/doi.org\/10.1210\/edrv.22.4.0435","journal-title":"Endocr Rev"},{"issue":"6","key":"464_CR17","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1210\/jc.2006-2570","volume":"92","author":"J Jansen","year":"2007","unstructured":"Jansen J, Friesema EC, Kester MH, Milici C, Reeser M, Gruters A, Barrett TG, Mancilla EE, Svensson J, Wemeau JL, Busi da Silva Canalli MH, Lundgren J, McEntagart ME, Hopper N, Arts WF, Visser TJ (2007) Functional analysis of monocarboxylate transporter 8 mutations identified in patients with X-linked psychomotor retardation and elevated serum triiodothyronine. J Clin Endocrinol Metab 92(6):2378\u20132381. \nhttps:\/\/doi.org\/10.1210\/jc.2006-2570","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"464_CR18","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1210\/en.2015-1933","volume":"157","author":"J Johannes","year":"2016","unstructured":"Johannes J, Jayarama-Naidu R, Meyer F, Wirth EK, Schweizer U, Schomburg L, Kohrle J, Renko K (2016) Silychristin, a Flavonolignan derived from the Milk thistle, is a potent inhibitor of the thyroid hormone transporter MCT8. Endocrinology 157(4):1694\u20131701. \nhttps:\/\/doi.org\/10.1210\/en.2015-1933","journal-title":"Endocrinology"},{"issue":"4","key":"464_CR19","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1159\/000371466","volume":"83","author":"JH Kim","year":"2015","unstructured":"Kim JH, Kim YM, Yum MS, Choi JH, Lee BH, Kim GH, Yoo HW (2015) Clinical and endocrine features of two Allan-Herndon-Dudley syndrome patients with monocarboxylate transporter 8 mutations. Horm Res Paediatr 83(4):288\u2013292. \nhttps:\/\/doi.org\/10.1159\/000371466","journal-title":"Horm Res Paediatr"},{"issue":"10","key":"464_CR20","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1177\/0883073814555189","volume":"30","author":"R La Piana","year":"2015","unstructured":"La Piana R, Vanasse M, Brais B, Bernard G (2015) Myelination delay and Allan-Herndon-Dudley syndrome caused by a novel mutation in the SLC16A2 gene. J Child Neurol 30(10):1371\u20131374. \nhttps:\/\/doi.org\/10.1177\/0883073814555189","journal-title":"J Child Neurol"},{"issue":"12","key":"464_CR21","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1177\/0883073815578524","volume":"30","author":"Maria Gisele Matheus","year":"2015","unstructured":"Matheus MG, Lehman RK, Bonilha L, Holden KR (2015) Redefining the pediatric phenotype of X-linked Monocarboxylate transporter 8 (MCT8) deficiency: implications for diagnosis and therapies. J Child Neurol. \nhttps:\/\/doi.org\/10.1177\/0883073815578524","journal-title":"Journal of Child Neurology"},{"issue":"5","key":"464_CR22","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1172\/JCI70324","volume":"124","author":"S Mayerl","year":"2014","unstructured":"Mayerl S, Muller J, Bauer R, Richert S, Kassmann CM, Darras VM, Buder K, Boelen A, Visser TJ, Heuer H (2014) Transporters MCT8 and OATP1C1 maintain murine brain thyroid hormone homeostasis. J Clin Invest 124(5):1987\u20131999. \nhttps:\/\/doi.org\/10.1172\/JCI70324","journal-title":"J Clin Invest"},{"issue":"1","key":"464_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/endo-117-1-1","volume":"117","author":"JA Mol","year":"1985","unstructured":"Mol JA, Visser TJ (1985) Synthesis and some properties of sulfate esters and sulfamates of iodothyronines. Endocrinology 117(1):1\u20137. \nhttps:\/\/doi.org\/10.1210\/endo-117-1-1","journal-title":"Endocrinology"},{"issue":"3","key":"464_CR24","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1002\/humu.23140","volume":"38","author":"F Novara","year":"2017","unstructured":"Novara F, Groeneweg S, Freri E, Estienne M, Reho P, Matricardi S, Castellotti B, Visser WE, Zuffardi O, Visser TJ (2017) Clinical and molecular characteristics of SLC16A2 (MCT8) mutations in three families with the Allan-Herndon-Dudley syndrome. Hum Mutat 38(3):260\u2013264. \nhttps:\/\/doi.org\/10.1002\/humu.23140","journal-title":"Hum Mutat"},{"issue":"2","key":"464_CR25","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1297\/cpe.25.23","volume":"25","author":"E Ono","year":"2016","unstructured":"Ono E, Ariga M, Oshima S, Hayakawa M, Imai M, Ochiai Y, Mochizuki H, Namba N, Ozono K, Miyata I (2016) Three novel mutations of the MCT8 (SLC16A2) gene: individual and temporal variations of endocrinological and radiological features. Clin Pediatr Endocrinol 25(2):23\u201335. \nhttps:\/\/doi.org\/10.1297\/cpe.25.23","journal-title":"Clin Pediatr Endocrinol"},{"issue":"1","key":"464_CR26","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1086\/431313","volume":"77","author":"CE Schwartz","year":"2005","unstructured":"Schwartz CE, May MM, Carpenter NJ, Rogers RC, Martin J, Bialer MG, Ward J, Sanabria J, Marsa S, Lewis JA, Echeverri R, Lubs HA, Voeller K, Simensen RJ, Stevenson RE (2005) Allan-Herndon-Dudley syndrome and the monocarboxylate transporter 8 (MCT8) gene. Am J Hum Genet 77(1):41\u201353. \nhttps:\/\/doi.org\/10.1086\/431313","journal-title":"Am J Hum Genet"},{"issue":"3","key":"464_CR27","first-page":"446","volume":"47","author":"RE Stevenson","year":"1990","unstructured":"Stevenson RE, Goodman HO, Schwartz CE, Simensen RJ, McLean WT Jr, Herndon CN (1990) Allan-Herndon syndrome. I. Clinical studies. Am J Hum Genet 47(3):446\u2013453","journal-title":"Am J Hum Genet"},{"issue":"6","key":"464_CR28","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1177\/0883073812450944","volume":"28","author":"D Tonduti","year":"2013","unstructured":"Tonduti D, Vanderver A, Berardinelli A, Schmidt JL, Collins CD, Novara F, Genni AD, Mita A, Triulzi F, Brunstrom-Hernandez JE, Zuffardi O, Balottin U, Orcesi S (2013) MCT8 deficiency: extrapyramidal symptoms and delayed myelination as prominent features. J Child Neurol 28(6):795\u2013800. \nhttps:\/\/doi.org\/10.1177\/0883073812450944","journal-title":"J Child Neurol"},{"issue":"6","key":"464_CR29","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.stem.2017.04.002","volume":"20","author":"GD Vatine","year":"2017","unstructured":"Vatine GD, Al-Ahmad A, Barriga BK, Svendsen S, Salim A, Garcia L, Garcia VJ, Ho R, Yucer N, Qian T, Lim RG, Wu J, Thompson LM, Spivia WR, Chen Z, Van Eyk J, Palecek SP, Refetoff S, Shusta EV, Svendsen CN (2017) Modeling psychomotor retardation using iPSCs from MCT8-deficient patients indicates a prominent role for the blood-brain barrier. Cell Stem Cell 20(6):831\u2013843 e5. \nhttps:\/\/doi.org\/10.1016\/j.stem.2017.04.002","journal-title":"Cell Stem Cell"},{"issue":"1","key":"464_CR30","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1002\/ana.21579","volume":"65","author":"C Vaurs-Barriere","year":"2009","unstructured":"Vaurs-Barriere C, Deville M, Sarret C, Giraud G, Des Portes V, Prats-Vinas JM, De Michele G, Dan B, Brady AF, Boespflug-Tanguy O, Touraine R (2009) Pelizaeus-Merzbacher-like disease presentation of MCT8 mutated male subjects. Ann Neurol 65(1):114\u2013118. \nhttps:\/\/doi.org\/10.1002\/ana.21579","journal-title":"Ann Neurol"},{"issue":"1","key":"464_CR31","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1002\/humu.20808","volume":"30","author":"WE Visser","year":"2009","unstructured":"Visser WE, Jansen J, Friesema EC, Kester MH, Mancilla E, Lundgren J, van der Knaap MS, Lunsing RJ, Brouwer OF, Visser TJ (2009) Novel pathogenic mechanism suggested by ex vivo analysis of MCT8 (SLC16A2) mutations. Hum Mutat 30(1):29\u201338. \nhttps:\/\/doi.org\/10.1002\/humu.20808","journal-title":"Hum Mutat"},{"issue":"3","key":"464_CR32","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1152\/physrev.2001.81.3.1097","volume":"81","author":"PM Yen","year":"2001","unstructured":"Yen PM (2001) Physiological and molecular basis of thyroid hormone action. Physiol Rev 81(3):1097\u20131142. \nhttps:\/\/doi.org\/10.1152\/physrev.2001.81.3.1097","journal-title":"Physiol Rev"},{"issue":"1-2","key":"464_CR33","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.mce.2005.11.030","volume":"246","author":"PM Yen","year":"2006","unstructured":"Yen PM, Ando S, Feng X, Liu Y, Maruvada P, Xia X (2006) Thyroid hormone action at the cellular, genomic and target gene levels. Mol Cell Endocrinol 246(1-2):121\u2013127. \nhttps:\/\/doi.org\/10.1016\/j.mce.2005.11.030","journal-title":"Mol Cell Endocrinol"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-019-00464-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11011-019-00464-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-019-00464-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,20]],"date-time":"2020-07-20T23:28:32Z","timestamp":1595287712000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11011-019-00464-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,22]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["464"],"URL":"https:\/\/doi.org\/10.1007\/s11011-019-00464-7","relation":{},"ISSN":["0885-7490","1573-7365"],"issn-type":[{"value":"0885-7490","type":"print"},{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,22]]},"assertion":[{"value":"18 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The authors have nothing to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure statement"}}]}}